Single User License
INR 168725
Site License
INR 337450
Corporate User License
INR 506175

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Macular Degeneration Global Clinical Trials Review, H1

Macular Degeneration Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Macular Degeneration Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Macular Degeneration Global Clinical Trials Review, H1, 2015" provides an overview of Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Macular Degeneration 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Macular Degeneration 25

Subjects Recruited Over a Period of Time 33

Clinical Trials by Sponsor Type 34

Prominent Sponsors 35

Top Companies Participating in Macular Degeneration Therapeutics Clinical Trials 36

Prominent Drugs 37

Latest Clinical Trials News on Macular Degeneration 38

Apr 30, 2015: Ocata Therapeutics Announces Positive Results in Treating Macular Degeneration Using Fully Differentiated Stem Cell-Derived Retinal Pigment Epithelium Cells in Asian Patients 38

Clinical Trial Profiles 39

Clinical Trial Overview of Top Companies 39

Novartis AG 39

Clinical Trial Overview of Novartis AG 39

F. Hoffmann-La Roche Ltd. 47

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47

Bayer AG 51

Clinical Trial Overview of Bayer AG 51

Pfizer Inc. 54

Clinical Trial Overview of Pfizer Inc. 54

Regeneron Pharmaceuticals, Inc. 57

Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 57

Ophthotech Corp. 59

Clinical Trial Overview of Ophthotech Corp. 59

Actavis plc 61

Clinical Trial Overview of Actavis plc 61

QLT Inc. 62

Clinical Trial Overview of QLT Inc. 62

GlaxoSmithKline Plc 63

Clinical Trial Overview of GlaxoSmithKline Plc 63

Eyetech Pharmaceuticals, Inc. 64

Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 64

Clinical Trial Overview of Top Institutes / Government 65

National Eye Institute 65

Clinical Trial Overview of National Eye Institute 65

Medical University of Vienna 67

Clinical Trial Overview of Medical University of Vienna 67

King's College Hospital NHS Foundation Trust 68

Clinical Trial Overview of King's College Hospital NHS Foundation Trust 68

Manhattan Eye Ear & Throat Hospital 69

Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 69

Vitreous-Retina-Macula Consultants of New York 70

Clinical Trial Overview of Vitreous-Retina-Macula Consultants of New York 70

Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 71

Clinical Trial Overview of Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 71

Kagawa University 72

Clinical Trial Overview of Kagawa University 72

Lawson Health Research Institute 73

Clinical Trial Overview of Lawson Health Research Institute 73

Nagoya City University 74

Clinical Trial Overview of Nagoya City University 74

The Johns Hopkins University 75

Clinical Trial Overview of The Johns Hopkins University 75

Five Key Clinical Profiles 76

Appendix 113

Abbreviations 113

Definitions 113

Research Methodology 114

Secondary Research 114

About GlobalData 115

Contact Us 115

Disclaimer 115

Source 115

List of Figures

Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 33

Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 34

Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 35

Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 36

Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 37

GlobalData Methodology 114

List of Tables

Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2015* 7

Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Macular Degeneration Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Macular Degeneration Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Macular Degeneration Therapeutics, Global, Terminated Clinical Trials, 2015* 28

Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 33

Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 34

Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 35

Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 36

Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 37

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 39

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 47

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 51

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 54

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 57

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthotech Corp., 2015* 59

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 61

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 62

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 63

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015* 64

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 65

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 67

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College Hospital NHS Foundation Trust, 2015* 68

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2015* 69

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Vitreous-Retina-Macula Consultants of New York, 2015* 70

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi, 2015* 71

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagawa University, 2015* 72

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2015* 73

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University, 2015* 74

Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 75

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novartis AG

F. Hoffmann-La Roche Ltd.

Bayer AG

Pfizer Inc.

Regeneron Pharmaceuticals, Inc.

Ophthotech Corp.

Actavis plc

QLT Inc.

GlaxoSmithKline Plc

Eyetech Pharmaceuticals, Inc.

Macular Degeneration Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Macular Degeneration, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com